FL H8019

Recognizes May 1-7, 2023, as "Tardive Dyskinesia Awareness Week" in Florida and encourages Floridians to become better informed about the disorder

Notes that tardive dyskinesia is an involuntary movement disorder characterized by uncontrollable, abnormal, and repetitive movements caused by prolonged use of dopamine receptor blocking agents used to treat mental health conditions and gastrointestinal disorders

States that more than 600,000 people in the United States suffer from tardive dyskinesia with approximately 70 percent undiagnosed, and recommends regular screening for patients taking dopamine receptor blocking agents

Highlights that the National Organization for Tardive Dyskinesia is headquartered in Florida and provides resources through TDhelp.org for people with the disorder

Notes that two new treatments for tardive dyskinesia have been approved by the Food and Drug Administration